FIGS shares have climbed 148.5% in the past six months, reflecting strong investor confidence in its medical apparel offerings and growth strategy. The stock’s rally has been underpinned by positive market sentiment and expanding distribution partnerships.

Analysts have lifted the 2026 EPS consensus by $0.09 over the past 30 days, bringing it to $0.19 per share. This upward revision suggests improved profitability expectations driven by efficient cost management and accelerating revenue growth prospects.

FIGS carries a Zacks Rank #1 (Strong Buy) in the Retail-Wholesale sector, positioning it ahead of many peers. Its robust ranking highlights outperforming earnings revisions and favorable industry dynamics supporting continued share gains.